Orocil Lido® (Benzoxonium Chloride, Lidocaine Hydrochloride)

Benzoxonium chloride, the active ingredient in Orocil Lido®, is an antiseptic presented as a solution for topical oral use. It provides antimicrobial protection and, together with lidocaine hydrochloride, offers local pain relief for conditions such as oral mucositis, sore throat and post‑dental‑procedure discomfort. GNH USA supplies Orocil Lido® as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orocil Lido, an oral antiseptic and local anesthetic, is employed to manage conditions affecting the oral mucosa.

- Oral mucositis: reduces pain and inflammation in patients undergoing chemotherapy or radiotherapy. - Sore throat: provides symptomatic relief of throat discomfort. - Dental procedures: offers topical antisepsis and anesthesia during minor oral surgeries.

Adverse reactions may occur with Orocil Lido use.

Common Side Effects: - Mild oral irritation: transient discomfort at the site of application. - Transient numbness: short‑lasting loss of sensation in the mouth. - Taste alteration: temporary change in taste perception. - Mild burning sensation: brief feeling of heat or sting. - Mild allergic reaction: rash or mild itching. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Prolonged numbness: extended loss of sensation beyond expected duration. - Mucosal ulceration: development of sores in the oral lining. - Systemic lidocaine toxicity: neurological symptoms such as dizziness or seizures. - Angioedema: swelling of the face, lips or tongue. - Severe local irritation: intense pain or inflammation requiring medical attention.

Before using Orocil Lido, consider the following precautions.

- Allergy assessment: verify no known hypersensitivity to quaternary ammonium compounds or lidocaine. - Pregnancy and lactation: use only if clearly needed; consult a healthcare professional. - Age restrictions: not recommended for children under a specified age without professional guidance. - Concurrent oral medications: avoid simultaneous use with other topical anesthetics to prevent additive effects. - Cardiac conditions: caution in patients with conduction disorders due to lidocaine component. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Potential drug interactions should be reviewed prior to therapy.

Major Interactions (Avoid): - Systemic lidocaine‑containing products: risk of cumulative toxicity. - Other local anesthetics: additive nerve block may increase numbness. - Anticholinergic agents: may exacerbate oral dryness.

Moderate Interactions (Monitor Closely): - Anticoagulants: possible increased bleeding if mucosal injury occurs. - Alcohol‑based mouthwashes: may heighten oral irritation. - CYP450 inhibitors: may affect lidocaine metabolism, requiring observation. - Herbal supplements with sedative properties: monitor for enhanced systemic effects.